NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

PDS Biotechnology Corporation (NASDAQ: PDSB)

 
PDSB Technical Analysis
5
As on 15th Jul 2025 PDSB SHARE Price closed @ 1.17 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.51 & Strong Sell for SHORT-TERM with Stoploss of 4.98 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

PDSBSHARE Price

Open 1.22 Change Price %
High 1.23 1 Day -0.06 -4.88
Low 1.15 1 Week -0.16 -12.03
Close 1.17 1 Month -0.21 -15.22
Volume 390186 1 Year -4.13 -77.92
52 Week High 6.59 | 52 Week Low 0.94
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
NVDA 170.70 4.04%
NCNA 0.05 0.00%
OPEN 1.04 15.56%
LMDX 0.02 0.00%
AKTS 0.04 0.00%
AMD 155.61 6.41%
LCID 2.33 2.64%
CAN 0.87 -10.31%
TSLA 310.78 -1.93%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
CYCC 12.33 272.51%
NBSTU 12.99 220.74%
NDRAW 0.03 200.00%
HCVIU 9.00 159.37%
 
NASDAQ USA Top Losers Stocks
TBIO 0.02 -93.33%
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
AXDX 0.03 -66.67%
TFFP 0.06 -62.50%
HEPA 0.12 -62.50%
 
 
PDSB
Daily Charts
PDSB
Intraday Charts
Whats New @
Bazaartrend
PDSB
Free Analysis
 
PDSB Important Levels Intraday
RESISTANCE1.32
RESISTANCE1.27
RESISTANCE1.24
RESISTANCE1.21
SUPPORT1.13
SUPPORT1.10
SUPPORT1.07
SUPPORT1.02
 
PDSB Forecast July 2025
4th UP Forecast7.09
3rd UP Forecast5.19
2nd UP Forecast4.02
1st UP Forecast2.84
1st DOWN Forecast-0.5
2nd DOWN Forecast-1.68
3rd DOWN Forecast-2.85
4th DOWN Forecast-4.75
 
PDSB Weekly Forecast
4th UP Forecast2.71
3rd UP Forecast2.22
2nd UP Forecast1.91
1st UP Forecast1.61
1st DOWN Forecast0.73
2nd DOWN Forecast0.43
3rd DOWN Forecast0.12
4th DOWN Forecast-0.37
 
PDSB Forecast2025
4th UP Forecast12.4
3rd UP Forecast8.8
2nd UP Forecast6.57
1st UP Forecast4.35
1st DOWN Forecast-2.01
2nd DOWN Forecast-4.23
3rd DOWN Forecast-6.46
4th DOWN Forecast-10.06
 
 
PDSB Other Details
Segment EQ
Market Capital 343359488.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
PDSB Address
PDSB
 
PDSB Latest News
 
Your Comments and Response on PDS Biotechnology Corporation
 
PDSB Business Profile
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma. In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey. Address: 25B Vreeland Road, Florham Park, NJ, United States, 07932
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service